
The price history is unavailable right now.
| 1W | 1M | 6M | 1Y | 5Y | |
|---|---|---|---|---|---|
| Stock | - | - | - | - | - |
| SPY | - | - | - | - | - |
Historical total returns · Dividends reinvested
Nothing in its numbers stands out right now.
No weak spot in its numbers right now.
Loading…
No company summary is available right now.
A 67-Year-Old With $750,000 in Pfizer, Enterprise Products and UPS Collects $3,765 a Month in Dividends. How Safe Is Each Check?tikr.com · 1 h ago
Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in RevenueThe Motley Fool · 2 h ago
Pfizer CEO: ‘China will be my major competition by 2030’pharmaceutical-technology.com · 4 h ago
Drug and Gene Delivery Devices - Global Strategic Business Report 2026: Capitalize on 8.1% CAGR to Secure the $1.2 Billion Market by 2032 as AbbVie, Moderna, Pfizer and Novartis AccelerateYahoo Finance · 6 h ago
Pfizer (PFE) Re Enters Obesity Drugs With Metsera AcquisitionYahoo Finance · 20 h ago